Navigation Links
Karmanos Cancer Institute Researchers Study New Drug Combinations to Treat Childhood Leukemia
Date:4/21/2009

ed to treat epilepsy. They found the two drugs worked together to dramatically stimulate cell death.

"We considered an old drug for a new use," Dr. Ge said. "It looks like the increased drug activity or synergy is not due to the transport or delivery of clofarabine, but to enhanced cell death. We were so pleased with the results."

AML afflicts mostly adults -- about 10,000 new cases each year -- and strikes older children. Acute lymphoblastic leukemia usually affects children between the ages of 2 to 5 and is generally easier to treat. Treatment advancements for AML, however, have been less successful.

Dr. Ge said researchers at Karmanos discovered the synergy between VPA and clofarabine only a few months ago, though departmental research has spanned some 15 years in the field of treating childhood leukemias. The current research represents a unique partnership between Dr. Ge, his Karmanos colleagues, and Jeffrey W. Taub, M.D., a pediatric oncologist at Children's Hospital of Michigan, also in Detroit.

Dr. Ge expects that their findings will move into the clinical phase in the next few years. St. Jude Children's Research Hospital in Memphis, Tenn. Is now conducting its own clinical drug trial studying the combined effects of VPA and cytarabine to treat newly diagnosed AML patients 21 years old and younger.

"This is truly translational research," Dr. Ge said. "We really want to translate what we do in the laboratory to the clinic and hopefully save more lives."

Located in mid-town Detroit, MI, the Barbara Ann Karmanos Cancer Institute is one of 40 National Cancer Institute-designated comprehensive cancer centers in the United States. Caring for more than 6,000 new patients annually on a budget of $216 million, conducting more than 700 cancer-specific scientific investigation programs and clinical trials, the Karmanos Cancer Institute is among the na
'/>"/>

SOURCE Barbara Ann Karmanos Cancer Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference
2. DNA Vaccine Developed at the Karmanos Cancer Institute Fights HER2-Positive Cancers
3. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
4. Karmanos Cancer Institute Researchers Show Phase I Immunotherapy with Armed T Cells Improve Overall Survival of Metastatic Breast Cancer Patients
5. Karmanos Cancer Institute Research Supports Role of Inflammation to Determine Lung Cancer Risk, Particularly in African-American Women
6. Karmanos Researchers Study the Impact of Galectin-3 on Breast Cancer Disparity in Caucasian and Asian Women
7. Karmanos Researchers Find Non-Toxic Agents Added to Conventional Chemotherapy Decrease Survival of Colon Cancer Cells
8. First Candidate from Esperances Targeted Anti-cancer Platform, EP-100, Establishes Preclinical Proof of Concept
9. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
10. Genes Identified That Enhance Tumor Cell Sensitivity to CTIs Cancer Drug Brostallicin
11. Muscadine Grape Skin Dietary Supplement Protects against Cancer Therapy Radiation Side Effects

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)..., Nov. 20 BD (Becton, Di...d the completion of its acquisition of HandyLab, I...elops and manufactures molecular diagnostic assays...nd HandyLab announced an exclusive agreement for B... the HandyLab Jaguar(TM) platform, the first fully...
(Date:11/19/2009).... 19 Warner Chilcott plc (Nasdaq: ...sly announced secondary offering of 20,000,000 of ...2.25 per share. The selling shareholders include ...erchant Banking, J.P. Morgan Partners (advised by ...rtain other institutional investors and members of...
(Date:11/19/2009)...ov. 19 In a series of ne..., Heska Corporation (Nasdaq: HSKA ) ("Heska" or t...w and improved website. The upgraded site is the ...rogramming to align the site with the company,s ne...go: http://www.newscom.com/cgi-bin/prnh/20000622...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Journal of Alzheimers Disease once again achieves significant impact factor increase 51463 1Building memories with actin 9236 1Building memories with actin 9236 2Medical use for waste television screens 9232 1
...AS VEGAS, Dec. 11 CardioVascular BioTherapeutics,...hat two additional hospitals in the United States ...II clinical trial for the treatment of severe coro...t Institute Foundation in Minneapolis MN, and Prin... , Mercy Hospital Fairfield (Ohio) and The Ch...
...RISBANE, Calif., Dec. 10 InterMune, Inc.,(Nasdaq:...results in January 2009,from its Phase 1b clinical...ombination with standard-of-care Pegasys(R) (pegin...4 days of treatment in treatment-naive patients,ch...) genotype 1. ITMN-191 is,being developed in coll...
Other Medicine Technology:CVBT Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial 2InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009 2InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009 3
(Date:11/20/2009)...O, Nov. 20 The American...d and Drug Administration (FDA) to establish appro...ls. ,, Citing concern about the safety of whit... the benefit of professional consultation or exami... application of chemically based tooth whitening o...
(Date:11/20/2009)... HAIFA, Israel, November 20 /PRNewswire-FirstCall/..., http://www.CVSLMEDICAL.COM , a leading,develope...oday announced that,the company,s Board of Directo...Europe, Canada and the Far East for its proprietar... for all angioplasty (PCTA) procedures. , ...
(Date:11/20/2009)...AS, Nov. 20 The followi...ctor of the Nevada Health Care Association: ,, ...s and thanks Senate Majority Leader Harry Reid for... toward our goal of protecting every Nevada senior...d preserving the strength and viability of our sta...
(Date:11/20/2009)...blished online November 20 in the Journal of the ...ed fears and hopes that often appear in news cover...dance for both the media and journals to help alle...., and Steven Woloshin, M.D., M.S., of Center for ...for Health Policy and Clinical Practice in New Ham...
(Date:11/20/2009)...sure readings in children with chronic kidney dise... doctor,s office visits increasing a child,s risk... from Johns Hopkins Children,s Center and other in...e in the Journal of American Society of Nephrology...ements obtained during regular doctor visits to re...
Breaking Medicine News(10 mins):Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:High blood pressure easy to miss in children with kidney disease 2
... Nearly six million people in the UK have h...million people have had to claim on their home ins...diff, UK (PRWEB) August 1, 2008 -- Nearly six mill...,Research from Confused.com found that some botche...
...s for action to protect, care for children impacte...- Mexico City event a chance to spur help for mill...rable children, MEXICO CITY, Aug. 1 A leading hu...tments to end,mother-to-child transmission of the ...
... breathing (also known as sleep apnea) is associat...ew results from the Wisconsin Sleep Cohort, an 18-... Heart, Lung, and Blood Institute (NHLBI) of the N...e times more likely to die from any cause compared...
...ly 31 Covance Inc. (NYSE:,CVD), a leading provide...at,its central laboratory services received Merck ...Award., Covance Central Laboratory Services is on...ributions towards the Key,Business Result (KBR) fo...
...According to recent,reporting, including today,s W....com/wp-dyn/content/article/2008/07/30/AR20080730 ...ng a draft proposed,regulation that, if enacted, w... about their care. As a leading health,care provid...
...ly 31 ev3 Inc. (Nasdaq:,EVVV) today announced tha...,Tracy, chief communications officer are scheduled...bal Growth Conference on Tuesday, August 12,2008 a..., To access the webcast, go to the investors, sec...
Other Medicine News:Health News:DIY Disasters Cost the Average Brit 669.58, Says Confused.com* 2Health News:DIY Disasters Cost the Average Brit 669.58, Says Confused.com* 3Health News:International AIDS Conference an 'Expensive Talking Shop' Unless More Done for Children 2Health News:International AIDS Conference an 'Expensive Talking Shop' Unless More Done for Children 3Health News:Sleep apnea linked to increased risk of death 2Health News:Covance Recognized for Outstanding Performance by Merck & Co., Inc. 2Health News:SPOKESPERSON AVAILABILTY: Planned Parenthood President Available for Interviews on Proposed HHS Regulations 2
Invertertube Surgical Microscope
... This 19 gauge universal irrigating chopper is des...ei. It features a bullet-shaped head for easy ins...ger" tip for dividing and chopping the nucleus. I...nts from underneath the iris which can be located ...
MRI Compatible Syringe Pump
Safe-Cross RF System
Medicine Products: